Hyphens Pharma International Ltd – Franchise Expands With Acquisitions - Trader Hub | I3investor

Sign In

Trader Hub

Blog Headlines (by Date) Blog Index

Hyphens Pharma International Ltd – Franchise Expands With Acquisitions

  • 1H22 revenue and PATMI were 54%/67% of our FY22e forecast. Earnings were above expectations due to a then higher-than-expected earnings contribution from newly acquired Novem Ltd and associates.
  • Underlying organic growth was an 11% YoY rise in PATMI to S$4.8mn. Growth was broad-based across specialty pharma and proprietary brands.
  • We maintain our FY22e earnings. We expect some upfront staff and technology costs in 2H22 with the establishment of DocMed to develop a healthcare platform for doctors, drug companies and other medical vendors.  Our BUY recommendation and DCF target price of S$0.43 is maintained. With Novem, Hyphens can profitably develop the public sector channel for its specialty products to complement its strength in private sector clinics.


The Positive

+ Revenue growth across key segments. Specialty pharma revenue surged 45% YoY in 1H22 to S$48mn. Excluding Novem, organic growth was 18% YoY to S$39mn. The return of more elective surgeries and other visits postponed during the pandemic were some drivers of demand. Proprietary brands growth of 16% YoY was led by key brands in dermatological (Ceradan and TDF) and health supplements (Ocean Health).


The Negative

– Loss of Biosensor. Hyphens announced it has amicably ceased the distribution of Biosensor by the end of 2022. Biosensor contributed 6% of revenue in 1H22 catering to the Vietnam market. All related costs and inventories will be wound down as the distribution agreement ends.



Hyphens continue to take steps in expanding its proprietary brands in the region. New Ocean Heath products (Omega 3, Vitamin D3) are to be launched in Malaysia and Vietnam. An exclusive license and supply agreement with Lederlon for the treatment of osteoarthritis has been inked.


Source: Phillip Capital Research - 29 Aug 2022

Share this

Related Stocks

Chart Stock Name Last Change Volume
Hyphens Pharma 0.28 0.00 (0.00%) 2,000
  Be the first to like this.

286  207  220  678 

Top 10 Active Counters
 Seatrium 0.134+0.003 
 HSI 19000MBeC.. 0.071+0.02 
 HSI 16600MBeP.. 0.061-0.022 
 NikkoAM-STC A.. 0.809+0.009 
 HSI 15600MBeP.. 0.079-0.018 
 CapAllianz 0.0020.00 
 Rex Intl 0.1960.00 
 YZJ Shipbldg SGD 1.66-0.01 
 RH PetroGas 0.23+0.025 
 Genting Sing 0.845-0.01 


1. Singapore Considering Novel Carbon Credits for Coal Phaseout in Asia CEO Morning Brief
2. 3 Things You Need to Keep in Mind when Building Your REIT Investment Portfolio THE SINGAPOREAN INVESTOR
3. Potential Special Dividends from Singtel (SGX: Z74) reitsnewsletter
4. Blueprint for Prosperity: How to Set Financial Goals and Guage Success Effectively Collin Seow Remisier Blog
5. Singapore Aug Core Inflation Rises 3.4%, Seen Easing CEO Morning Brief